Host exonuclease SbcB and a phage-encoded SSB-like protein control activation of the DRT10 reverse transcriptase defense system

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Defense-associated reverse transcriptases (DRTs) employ diverse mechanisms of cDNA synthesis to protect bacteria against phage infection, yet their full diversity and regulatory logic remain poorly understood. Here we provide a mechanistic characterization of UG17 (DRT10), a class-2 system within the UG/Abi reverse transcriptase lineage, classifying it into three phylogenetically and architecturally distinct subtypes with subtype-specific ncRNAs and experimentally validating its role in phage defense. DRT10 operates as a tripartite module, comprising a structured ncRNA, a SLATT effector, and an RT that catalyzes processive synthesis of DNA containing 7 nt tandem repeats. The tandem-repeat cDNA intermediate accumulates as both first- and second-strand species. SbcB suppresses DRT10-mediated toxicity and appears to selectively degrade the second strand under basal conditions, while phage infection correlates with enhanced first-strand accumulation. A phage-encoded protein with predicted SSB-like architecture and a conserved C-terminal tip motif is required for efficient DRT10 activation during infection. Together, these findings establish DRT10 as a surveillance system whose activation threshold is jointly controlled by constitutive cDNA synthesis, host exonuclease activity, and a phage-encoded SSB-like trigger that perturbs host ssDNA metabolism. We propose a model in which accumulation of DRT10-derived cDNA triggers activation of the SLATT transmembrane effector to initiate immune defense.

Article activity feed